Feedback / Questions
pemvidutide (ALT-801) - Altimmune
https://www.globenewswire.com/news-release/2025/06/26/3105697/0/en/Altimmune-Announces-Positive-Topline-Results-from-the-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-the-Treatment-of-MASH.html
Jun 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next